Knockout of RGS1 notably increases the invasion and survival of helper Th1 cells and cytotoxic T lymphocytes (CTLs) in breast and lung cancer transplanted tumors, and effectively inhibits tumor growth in vivo, suggesting that RGS1 is a tumor promoter [31]. The gene discussed is RGS1; the disease is neoplasm.